Labgenius Pharma Collaborates With Sanofi On AI Antibody Program
04 Dec 2025 //
PRESS RELEASE
LabGenius Therapeutics Presents Poster At ESMO Immuno-Oncology
12 Nov 2025 //
BUSINESSWIRE
UK biotech raises £35M to develop solid tumor drugs based on machine learning
21 May 2024 //
ENDPTS
LabGenius Appoints Hendrik-Tobias Arkenau and Victor Greiff as Advisors
03 Apr 2023 //
BUSINESSWIRE

Market Place
Sourcing Support